THE UNIVERSITY of Queensland is seeking approval for human trials of a potential swine flu vaccine made using insect cells.
30/06/2009
AMERICAN Biotech Labs has announced it has been granted FDA approval to market it’s ASAP Wound Dressing Gel throughout the United States.
17/04/2009
SAGENT Pharmaceuticals has announced FDA approval of its Azithromycin for Injection therapy developed for treatment of bacterial infections.
31/03/2009
ABBOTT has announced the initiation of Mobility, a clinical trial into the safety and efficacy of the Absolute Pro Peripheral Self-Expanding Stent System in patients with iliac artery disease.
16/04/2009
THE CENTRES for Disease Control and Prevention (CDC) has reported additionally confirmed human infections of the Swine Influenza in the United States and internationally.
30/04/2009
SYNTHEMED has announced that the US Food and Drug Administration (FDA) has approved the Pre-market Approval (PMA) application for REPEL-CV Adhesion Barrier.
13/03/2009
ALCON has launched a website as an online resource for Patanase nasal allergy treatment.
20/03/2009
AGILENT Technologies has announced the launch of its web-based academic resource designed for scientists worldwide seeking information regarding funding, collaborations, teaching tools and internships.
03/04/2009
NOVARTIS has been granted Marketing Authorisation by theEuropean Commission for its Ixiaro Vaccine developed for the prevention of Japanese Encephalitis (JE).
06/04/2009
ENTERIX, manufacturer of a clinically proven bowel screening, has released a statement in relation to a factually incorrect story aired on the Channel 7 evening news bulletin in New South Wales and South Australia on Monday 11 May 2009.
12/05/2009
An Australian regenerative medicine company, Mesoblast, has been granted a key patent by the United States Patent and Trademark Office (USPTO), providing them with exclusive commercial protection for its bone tissue generating products through to at least 2019 in the US.
05/03/2010
A new stent graft can open vessels that become blocked or narrowed at the point where dialysis machines connect to the body. The stent has received approval from the US Food and Drug Administration.
16/02/2010
The US Food and Drug Administration (FDA) has approved Prevnar 13, a pneumococcal 13-valent conjugate vaccine for infants and young children ages 6 weeks through 5 years. This new vaccine extends the protection to six more types of the disease-causing bacteria than its predecessor Prevnar.
01/03/2010
Bayer has begun a clinical Phase I study to treat non-Hodgkins lymphoma (NHL) using a patient-specific vaccine derived from tobacco plants.
12/02/2010